Nevertheless, this immunosuppressive effect of HMGB1 is primarily observed in established tumors where the tumor environment likely contains high levels of ROS, suggesting that the inactive oxidized form of HMGB1 may be responsible for the observed tolerogenic effects in such scenarios. Here, HMGB1 is linked to neoplasm.